Alsarraj Jude, Hunter Kent W
Laboratory of Cancer Biology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Int J Breast Cancer. 2012;2012:670632. doi: 10.1155/2012/670632. Epub 2011 Oct 26.
Metastasis is an extremely complex process that accounts for most cancer-related deaths. Malignant primary tumors can be removed surgically, but the cells that migrate, invade, and proliferate at distant organs are often the cells that prove most difficult to target therapeutically. There is growing evidence that host factors outside of the primary tumors are of major importance in the development of metastasis. Recently, we have shown that the bromodomain-containing protein 4 or bromodomain 4 (Brd4) functions as an inherited susceptibility gene for breast cancer progression and metastasis. In this paper, we will discuss that host genetic background on which a tumor arises can significantly alter the biology of the subsequent metastatic disease, and we will focus on the role of Brd4 in regulating metastasis susceptibility.
转移是一个极其复杂的过程,是大多数癌症相关死亡的原因。恶性原发性肿瘤可以通过手术切除,但在远处器官迁移、侵袭和增殖的细胞往往是最难进行靶向治疗的细胞。越来越多的证据表明,原发性肿瘤之外的宿主因素在转移的发生中至关重要。最近,我们发现含溴结构域蛋白4(Brd4)作为乳腺癌进展和转移的一个遗传性易感基因发挥作用。在本文中,我们将讨论肿瘤发生的宿主遗传背景可显著改变后续转移性疾病的生物学特性,并将重点关注Brd4在调节转移易感性中的作用。